Stock ETFs Fall on Johnson & Johnson Vaccine News

After a respite on Thursday, stocks and index ETFs tumbled once again on Friday after a trial result from Johnson & Johnson’s coronavirus vaccine disappointed some investors. Fears about a retail trading battle between smaller and larger investing players continued. The Dow Jones Industrial...
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.